Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Other financing activities (2016 - 2022)

Nutex Health's Other financing activities history spans 8 years, with the latest figure at $81249.0 for Q3 2022.

  • For Q3 2022, Other financing activities rose 19716.83% year-over-year to $81249.0; the TTM value through Sep 2022 reached $210268.0, down 1.17%, while the annual FY2021 figure was $47875.0, 77.59% down from the prior year.
  • Other financing activities for Q3 2022 was $81249.0 at Nutex Health, up from $54166.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $3.9 million in Q1 2021 and bottomed at -$3.9 million in Q2 2021.
  • The 5-year median for Other financing activities is $54166.0 (2022), against an average of $159602.2.
  • The largest annual shift saw Other financing activities tumbled 1174.59% in 2021 before it skyrocketed 19716.83% in 2022.
  • A 5-year view of Other financing activities shows it stood at -$9171.0 in 2018, then surged by 5007.36% to $450054.0 in 2019, then plummeted by 52.82% to $212348.0 in 2020, then crashed by 77.65% to $47465.0 in 2021, then surged by 71.18% to $81249.0 in 2022.
  • Per Business Quant, the three most recent readings for NUTX's Other financing activities are $81249.0 (Q3 2022), $54166.0 (Q2 2022), and $27388.0 (Q1 2022).